Cantitate/Preț
Produs

Endocannabinoids: Handbook of Experimental Pharmacology, cartea 231

Editat de Roger G. Pertwee
en Limba Engleză Hardback – 5 oct 2015
There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced “autoprotection”, for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced “autoimpairment”. This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 229915 lei  6-8 săpt.
  Springer International Publishing – 23 aug 2016 229915 lei  6-8 săpt.
Hardback (1) 197377 lei  38-44 zile
  Springer International Publishing – 5 oct 2015 197377 lei  38-44 zile

Din seria Handbook of Experimental Pharmacology

Preț: 197377 lei

Preț vechi: 207766 lei
-5% Nou

Puncte Express: 2961

Preț estimativ în valută:
37785 41161$ 31697£

Carte tipărită la comandă

Livrare economică 14-20 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319208244
ISBN-10: 3319208241
Pagini: 450
Ilustrații: XII, 475 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 1.07 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Public țintă

Research

Cuprins

Endocannabinoids and their pharmacological actions. Biosynthesis and fate of endocannabinoids. Distribution of the endocannabinoid system. Endocannabinoids and neurotransmission in health and disease. Endocannabinoids and the immune system in health and disease. Genetic manipulation of the endocannabinoid system and some consequences of this. Modulators of endocannabinoid biosynthesis, metabolism and cellular uptake as potential medicines. Endocannabinoids and mental disorders. Endocannabinoids and neurodegenerative disorders. Endocannabinoids in multiple sclerosis and amyotrophic lateral sclerosis. Endocannabinoids and metabolic disorders. Endocannabinoids and the cardiovascular system in heath and disease. Endocannabinoids and the digestive tract and bladder in health and disease. Endocannabinoids and the endocrine system in health and disease. Endocannabinoids and the reproductive system in health and disease. Endocannabinoids and cell viability/cancer.

Caracteristici

Enriches understanding of the physiology, pathophysiology and pharmacology of the endocannabinoid system Illustrates potential treatment strategies Written by leading experts in the field